Posted BY: Billy | NwoReport
We’ve covered negative efficacy among the COVID jabbed and boosted, but this is that with a twist. Kaiser Permanente did some research relative to COVID “vaccination,” its insurance plans, and its healthcare business. Maybe they wanted to determine if the unvaccinated cost more. They discovered the opposite.
Kaiser did something unusual: it actually sequenced 16,418 positive COVID samples to determine the Omicron subvariant with which the enrollees were infected.
What it found was that for 4 out of 5 Omicron subvariants by 150 days (5 months) post shot, efficacy had fallen into negative territory, and Kaiser’s thrice-vaccinated enrollees were more likely to get COVID than the unvaccinated.